acute myocardial infarction
Conditions
Interventions
treatment group:Standardized secondary prevention medication for coronary heart disease combined with Qishen Yiqi Dropping Pills for treatment
control group:Standardize the combination of secondary prevention medication for coronary heart disease and placebo
Sponsors
Kaizhou District People's Hospital, Chongqing
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Met the diagnostic criteria; (2) onset =12 h; (3) aged 18–80 years, with no restriction on sex; (4) voluntarily participated in this study and provided written informed consent.
Exclusion criteria
Exclusion criteria: (1) History of myocardial infarction; (2) presence of cardiogenic shock; (3) cardiac arrest prior to enrollment; (4) severe cardiac complications such as ventricular septal perforation; (5) malignant tumors; impaired hepatic or renal function; severe pulmonary disease; or coagulation disorders; (6) pregnant or breastfeeding women; (7) allergy to the study medication; (8) currently taking Chinese herbal medicines or proprietary Chinese medicines with ingredients similar to Qishen Yiqi Dripping Pills; (9) participation in other drug clinical trials; (10) inability to complete the study or to comply with study requirements.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ultrasonic cardiogram; | — |
Secondary
| Measure | Time frame |
|---|---|
| NT-proBNP;6-minute walk test;Main symptom indicators in traditional Chinese medicine; | — |
Countries
China
Contacts
Public ContactXiaoxian Liao
Kaizhou District People's Hospital, Chongqing
Outcome results
None listed